MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-33-0016399
Lamet Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹4.52 Cr
▼ 22% YoY
Net loss · FY 2022
₹1.38 Cr
Net margin -30.5%
EBITDA · FY 2022
-₹1.22 Cr
EBITDA margin -27.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹55.55 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
89
Provident fund records
About Lamet Pharma Private Limited
Data last updated:
Lamet Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24296MH2015PTC265853. Its GSTIN is 27AACCL8778R1ZD (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rohini Jaiprakash Tiwari and Jaiprakash Bhagwatsharan Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹4.52 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹1.38 Cr (net margin -30.5%) and EBITDA of -₹1.22 Cr (EBITDA margin -27.1%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 16% over five years.
The company has about 89 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹55.55 Lakh on record. Court records list 9 cases involving the company, including 9 filed against it; 9 cases are pending.
Lamet Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0016399). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lametpharma.com.
Company details
CIN U24296MH2015PTC265853
Registration Number 265853
Incorporation Date 22 June 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0016399
Recognitions & Rankings of Lamet Pharma
Contact details
Lamet Pharma Private Limited's registered office is in Thane, Maharashtra. Its website is lametpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address101 1st Floor B65 Building Jaydeep Shantinagar C.H.S.Limited Sector Shantinagar Meera, Road (E), Thane, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lamet Pharma Private Limited, buy the company report.
Comprehensive company report
Lamet Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lamet Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lamet Pharma Private Limited, buy the company report.
Financials of Lamet Pharma Private Limited
FY 2022 filings availableLamet Pharma Private Limited reported revenue of ₹4.52 Cr (down 22% YoY) for FY 2022.
Revenue · FY 2022
₹4.52 Cr ▼ 22%
Net loss · FY 2022
₹1.38 Cr margin -30.5%
EBITDA · FY 2022
-₹1.22 Cr margin -27.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 29%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 112%
5 years · compounded
▼ 372%
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 22% fall in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.1% | ||||
| Net Profit Margin | -30.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lamet Pharma Private Limited, buy the company report.
Board of directors of Lamet Pharma Private Limited
Lamet Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohini Jaiprakash Tiwari | Director | 22 Jun 2015 | 11 Years 4 Months | Current |
| Jaiprakash Bhagwatsharan Tiwari | Director | 31 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Lamet Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medipaams India Private Limited | ₹4.52 Cr (FY 2024) | 13.0% | Mumbai, Maharashtra, India | |||
| Lamet Pharma Private Limitedthis company | ₹4.52 Cr (FY 2022) | -₹1.38 Cr | -30.5% | -22.0% | 89 | Thane, Maharashtra, India |
| Pacific Bioengineering Private Limited | ₹4.51 Cr (FY 2024) | -22.0% | Delhi, India | |||
| Nova Global Medicare Private Limited | ₹4.5 Cr (FY 2025) | -4.0% | Kolhapur, Maharashtra, India |
To see the full peer comparison of Lamet Pharma Private Limited, buy the company report.
Auditor
Lamet Pharma Private Limited is audited by K. K. A. B. & Co. LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. K. A. B. & Co. LLP | FY 2020 | 132029W/W100204 |
Shareholding
The shareholding of Lamet Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lamet Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹55.55 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2020 | 100354383 | Others | ₹55.55 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Lamet Pharma Private Limited has 9 court cases on record: 9 filed against it. All cases are pending.
Total cases
9
Filed against the company
9
Pending
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 9 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by Mestra Pharma Pvt.Ltd | Pending |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by M/S Foregen Health Care Ltd | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Unimedia Pharmaceticals Pvt Ltd-Shree Mohmadzahis A Mal | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Shree Mohmadzahis A Mal-Unimedia Pharmaceticals Pvt Ltd | Pending |
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by Meril Pharma Pvt.Ltd | Pending |
To see the full case history of Lamet Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lamet Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lamet Pharma Private Limited has a workforce of 89 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
89
Active EPFO establishments
1
Employee growth
-23.93%
GST
Lamet Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL8778R1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lamet Pharma Private Limited, buy the company report.
Recent activity
Lamet Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Abhishek Kumar Bhansali ceased to be Director on 27 Jul 2020.
AGM
Lamet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Lamet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai I.
Ceased
Abhishek Kumar Bhansali ceased to be Director.
Ceased
Varun Rajkumar Parekh ceased to be Director.
Charges
A charge with Others amounted to Rs. 55.55 Lakh with Charge ID 100354383 was registered on 30 Jun 2020.
Appointed
Jaiprakash Bhagwatsharan Tiwari was appointed as Director.
Appointed
Rohini Jaiprakash Tiwari was appointed as Director.
Incorporation
22 Jun 2015
Lamet Pharma Private Limited was registered on 22 Jun 2015 with Roc Mumbai I & aged 11 years 4 months as per MCA records.
Frequently asked questions
Lamet Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 2015 (11+ years old) and is registered under CIN U24296MH2015PTC265853.
Lamet Pharma has 2 current directors:
- Rohini Jaiprakash Tiwari - Director
- Jaiprakash Bhagwatsharan Tiwari - Director
The latest financial statements of Lamet Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Lamet Pharma is 27AACCL8778R1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lamet Pharma is U24296MH2015PTC265853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lamet Pharma has 9 court cases on record: 9 filed against it. 9 are pending.
Lamet Pharma was incorporated on 22 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lamet Pharma by revenue are Medipaams India Private Limited, Pacific Bioengineering Private Limited, Nova Global Medicare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Abhishek Kumar Bhansali ceased to be Director on 27 Jul 2020. Varun Rajkumar Parekh ceased to be Director on 27 Jul 2020. Jaiprakash Bhagwatsharan Tiwari was appointed as Director on 31 Jul 2015. Lamet Pharma has 4 board changes on record in total.
Yes, Lamet Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0016399).
Lamet Pharma can be reached through the website lametpharma.com. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages